Code intelligence

Z85.528 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code Z85.528.

Critical code riskView ICD-10 detail

Signal breakdown

2 shown · 2 total in platform

Risk: Critical
2

Critical

100%

0

High

0%

0

Routine

0%

0

Low

0%

New this month

+2

alerts added in last 30 days

Effective soon

no upcoming deadlines

Proposed LCD DL40435: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Noridian

Policy LCD-DL40435 · Oncology

Critical

Proposed LCD: Renal CA transcriptional biomarkers—comment by 10/11/26

Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Palmetto GBA

Policy LCD-DL40429 · Oncology

Critical

Proposed LCD: Molecular biomarkers for renal carcinoma tx decisions—comment by 1

Audit documentation

Building an audit file that includes Z85.528?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription